SIBN
Si-Bone Inc
NASDAQ: SIBN · HEALTHCARE · MEDICAL DEVICES
$12.39
+3.86% today
Updated 2026-04-30
Market cap
$546.85M
P/E ratio
—
P/S ratio
2.72x
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$12 – $22
Volume
0.6M
Si-Bone Inc (SIBN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-9.41%
Operating margin
-4.37%
ROE
-11.00%
ROA
-5.95%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $37.02M | $-10.90M | 91.78% | -28.96% | -29.45% |
| 2013 | $49.00M | $-6.15M | 91.16% | -10.81% | -12.56% |
| 2014 | $40.05M | $-27.81M | 83.77% | -65.66% | -69.42% |
| 2015 | $41.17M | $-28.15M | 86.89% | -64.18% | -68.38% |
| 2016 | $42.10M | $-20.59M | 87.73% | -41.72% | -48.90% |
| 2017 | $47.98M | $-23.04M | 89.35% | -36.16% | -48.01% |
| 2018 | $55.38M | $-17.45M | 91.27% | -21.61% | -31.51% |
| 2019 | $67.30M | $-38.40M | 89.91% | -53.50% | -57.06% |
| 2020 | $73.39M | $-43.70M | 87.87% | -52.55% | -59.54% |
| 2021 | $90.15M | $-56.57M | 88.43% | -57.31% | -62.75% |
| 2022 | $106.41M | $-61.26M | 85.24% | -56.02% | -57.57% |
| 2023 | $138.89M | $-43.34M | 78.78% | -33.79% | -31.20% |
| 2024 | $167.18M | $-30.91M | 79.03% | -21.08% | -18.49% |
| 2025 | $200.93M | $-18.91M | 79.57% | -11.11% | -9.41% |